References
- Bogoch A, Watts A, Thomas-Bachli C, Huber MUG, Kraemer K. Khan, Pneumonia of unknown etiology in wuhan, China: potential for international spread via commercial air travel. J. Trav. Med. 2020;27(2). doi:https://doi.org/10.1093/jtm/taaa008.
- Lu H, Stratton CW, Tang YW. outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J. Med. Virol. 2020;92(4):401–02. doi:https://doi.org/10.1002/jmv.25678.
- World Health Organization. Laboratory testing of human suspected cases of novel coronavirus (nCoV) infection: interim guidance; 2020 Jan 10. World Health Organization. https://apps.who.int/iris/handle/10665/330374. License: CC BY-NC-SA 3.0 IGO
- Calisher C, Carroll D, Colwell R, Corley RB, Daszak RP, Drosten C, Enjuanes L, Farrar J, Field H, Golding J. Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19. The Lancet. 2020;395(10226):e42–e43. doi:https://doi.org/10.1016/S0140-6736(20)30418-9.
- Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci. Trends. 2020;14(1):69–71. doi:https://doi.org/10.5582/bst.2020.01020.
- Weiss SR, Leibowitz JL. 2011. Coronavirus pathogenesis. Advances in Virus Research. Vol. 81. 85–164. Elsevier.
- Li G, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X. Coronavirus infections and immune responses. J. Med. Virol. 2020;92(4):424–432. doi:10.1002/jmv.25685.
- Yang D, Leibowitz JL. The structure and functions of coronavirus genomic 3′ and 5′ ends. Virus Res. 2015;206:120–33. doi:https://doi.org/10.1016/j.virusres.2015.02.025.
- Drosten C, Günther C,S, Preiser W, Van Der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New Eng. J. Of Med. 2003;348(20):1967–76. doi:https://doi.org/10.1056/NEJMoa030747.
- Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New Eng. J. Of Med. 2012;367(19):1814–20. doi:https://doi.org/10.1056/NEJMoa1211721.
- Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 2020;92(4):418–423.
- Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in microbio. 2016;24(6):490–502. doi:https://doi.org/10.1016/j.tim.2016.03.003.
- Zhao Z, Li H, Wu X, Zhong Y, Zhang K, Zhang YP, Boerwinkle E, Fu YX. Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol. Biol. 2004;4(1):21. doi:https://doi.org/10.1186/1471-2148-4-21.
- Woo PC, Lau SK, Huang Y, Yuen KY. K, Coronavirus diversity, phylogeny and interspecies jumping. Exp. Bio. And Med. 2009;234(10):1117–27. doi:https://doi.org/10.3181/0903-MR-94.
- Woo PC, Lau SK, Yip CC, Huang Y, Tsoi HW, Chan KH, Yuen KY. Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. J. Of Virol. 2006;80(14):7136–45. doi:https://doi.org/10.1128/JVI.00509-06.
- Benvenuto D, Giovannetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019‐new coronavirus epidemic: evidence for virus evolution. J. Med. Virol. 2020;92(4):455–59. doi:https://doi.org/10.1002/jmv.25688.
- Ceraolo C, Giorgi FM. Genomic variance of the 2019‐nCoV coronavirus. J. Med. Virol. 2020;92(5):522–28. doi:https://doi.org/10.1002/jmv.25700.
- Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565–74. doi:https://doi.org/10.1016/S0140-6736(20)30251-8.
- Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 2020;94(7). doi:https://doi.org/10.1128/JVI.00127-20.
- Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, Xing F, Liu J, Yip CCY, Poon RWS. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514–23. doi:https://doi.org/10.1016/S0140-6736(20)30154-9.
- Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. Jama. 2020;323(8):709–10. doi:https://doi.org/10.1001/jama.2020.1097.
- Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, Fang C, Huang D, Huang LQ, Huang Q, et al. Management, f. t. Z. H. o. W. U. N. C.; Research Team, E.-B. M. C. o. C. I. E.; Promotive Association for, M.; Health, C., A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil.Medi.Res. 2020;7:4.
- Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, et al. First Case of 2019 Novel Coronavirus in the United States. New Eng. J. Of Med. 2020;382(10):929–36. doi:https://doi.org/10.1056/NEJMoa2001191.
- WHO. How does COVID-19 Spread? Geneva: World Health Organization; 2020.
- Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, Xia S, Zhou W. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl.Pedi. 2020;9(1):51. doi:https://doi.org/10.21037/tp.2020.02.06.
- Jaimes JA, Millet JK, Stout AE, André NM, Whittaker GR. A tale of two viruses: the distinct spike glycoproteins of feline coronaviruses. Viruses. 2020;12(1):83. doi:https://doi.org/10.3390/v12010083.
- symptoms https://www.who.int/news-room/q-a-detail/q-a-coronaviruses#:~:text=symptoms. 16 march 2020.
- Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurve. 2020;25(3). doi:https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045.
- https://www.roche.com/media/releases/med-cor-2020-03-13.htm [Accessed 2020 Mar 30].
- Al Johani S, Hajeer AH. MERS-CoV diagnosis: an update. J. Of Inf.and Pub. Health. 2016;9(3):216–19. doi:https://doi.org/10.1016/j.jiph.2016.04.005.
- Kelly-Cirino C, Mazzola LT, Chua A, Oxenford CJ, Van Kerkhove MD. An updated roadmap for MERS-CoV research and product development: focus on diagnostics. BMJ Global Health. 2019;4(2):e001105. doi:https://doi.org/10.1136/bmjgh-2018-001105.
- Andersen PI, Ianevski A, Lysvand H, Vitkauskiene A, Oksenych V, Bjørås M, Telling K, Lutsar I, Dampis U, Irie Y. Discovery and development of safe-in-man broad-spectrum antiviral agents. Int. J. Of Inf. Dis. 2020;93:268–76. doi:https://doi.org/10.1016/j.ijid.2020.02.018.
- Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat. Comm. 2020;11(1):1–14. doi:https://doi.org/10.1038/s41467-019-13940-6.
- Kadam RU, Wilson IA. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc. Of the Nat. Acad. Of Sci. 2017;114(2):206–14. doi:https://doi.org/10.1073/pnas.1617020114.
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV). [Accessed 2020 Mar 15]. https://www.nature.com/articles/d41573-020-00016-0. 2020.
- Linghua LI, The efficacy of lopinavir plus ritonavir and arbidol against novel coronavirus infection (ELACOI). ClinicalTrials.gov Identifier: NCT04252885, https://clinicaltrials.gov/ct2/show/NCT042528. 2020.
- Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi:https://doi.org/10.1016/j.cell.2020.02.052.
- Lilly and incyte announce submission of NDA to FDA for oral once-daily baricitinib for treatment of moderate-to-severe rheumatoid arthritis. [Accessed 2020 Apr 1]. https://www.drugs.com/nda/baricitinib_160119.html.
- Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Stebbing J. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. The Lancet. 2020;395(10223):e30–e31. doi:https://doi.org/10.1016/S0140-6736(20)30304-4.
- Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531(7594):381–85. doi:https://doi.org/10.1038/nature17180.
- Lo MK, Jordan R, Arvey A, Sudhamsu J, Shrivastava-Ranjan P, Hotard AL, Flint M, McMullan LK, Siegel D, Clarke MO. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci. Rep. 2017;7(1):43395. doi:https://doi.org/10.1038/srep43395.
- Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–71. doi:https://doi.org/10.1038/s41422-020-0282-0.
- Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J. The ambiguous base-pairing and high substrate efficiency of T-705 (favipiravir) ribofuranosyl 5′-triphosphate towards influenza A virus polymerase. PloS One. 2013;8(7):e68347. doi:https://doi.org/10.1371/journal.pone.0068347.
- Mifsud EJ, Hayden FG, Hurt AC. Antivirals targeting the polymerase complex of influenza viruses. Antivir. Res. 2019;169:104545. doi:https://doi.org/10.1016/j.antiviral.2019.104545.
- Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149–150. doi:https://doi.org/10.1038/d41573-020-00016-0.
- Leneva IA, Russell RJ, Boriskin YS, Hay AJ. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antivir. Res. 2009;81(2):132–40. doi:https://doi.org/10.1016/j.antiviral.2008.10.009.
- The efficacy of lopinavir plus ritonavir and arbidol against novel coronavirus infection (ELACOI). [Accessed 2020 Apr 3]. https://clinicaltrials.gov/ct2/show/NCT04252885.
- Ng E. Coronavirus: are cocktail therapies for flu and HIV the magic cure?. South China Morning Post. Bangkok and Hangzhou hospitals put combination remedies to the test. [ Accessed 2020 Feb 4]. https://www.scmp.com/business/companies/article/3048888/could-cocktail-therapies-hiv-and-flu-be-magic-cure-new.
- Guo D. Old weapon for new enemy: drug repurposing for treatment of newly emerging viral diseases. Virolo. Sini. 2020;35:1–3.
- Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today’s diseases. The Lancet Inf. Dis. 2003;3(11):722–27. doi:https://doi.org/10.1016/S1473-3099(03)00806-5.
- Zeldin RK, Petruschke RA. Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. J. Of Antimirob. Chem. 2004;53(1):4–9. doi:https://doi.org/10.1093/jac/dkh029.
- Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. Jama. 2020;323(8):707–08. doi:https://doi.org/10.1001/jama.2020.0757.
- White AC Jr. Nitazoxanide: a new broad spectrum antiparasitic agent. Expert rev. of anti-infec. Therapy. 2004;2:43–49.
- McKay BLP, Drugmakers rush to develop vaccines against china virus the wall street journal. [Accessed 2020 Mar 22]. https://www.wsj.com/articles/drugmakers-rush-to-develop-vaccines-against-china virus11579813026.
- Inovio Pharmaceuticals Inc. Inovio selected by cepi to develop vaccine against new coronavirus inovio. [Accessed 2020 Mar 20]. http://ir.inovio.com/news-and-media/news/press-release-details/2020/Inovio-Selected-byCEPI-to-Develop-Vaccine-Against-New Coronavirus/default.aspx.
- University of Queensland Australia. Race to develop coronavirus vaccine. [Accessed 2020 Mar 22]. https://www.uq.edu.au/news/article/2020/01/race-develop-coronavirus-vaccine.
- Hennessy J Australia’s been asked to make a coronavirus vaccine at ‘unprecedented speed’ business insider. [Accessed 2020 Mar 25]. https://www.sciencealert.com/australian-scientists-asked-to-make-coronavirus-vaccine-atunprecedented-speed.
- Reinicke C, An obscure biotech stock skyrockets 38% after saying it’s testing a coronavirus antibody (vir). [Accessed 2020 Mar 28]. https://markets.businessinsider.com/news/stocks/vir-biotechnology-stock-price-surgescoronavirus-antibody-tests-crispr-2020-1-1028847912.
- VIR Vir biotechnology applying multiple platforms to address public health risk from wuhan coronavirus. [Accessed 2020 Mar 20]. https://investors.vir.bio/news-releases/news-release-details/vir-biotechnology-applyingmultiple-platforms-address-public.
- Xinhua, China cdc developing novel coronavirus vaccine xinhua. [Accessed 2020 Mar 29]. http://www.xinhuanet.com/english/2020-01/26/c_138734908.htm.
- Lee JHZW, Zhou L, Chinese scientists race to develop vaccine as coronavirus death toll jumps: South china morning post. https://www.scmp.com/news/china/society/article/3047676/numbercoronavirus-cases-china-doubles-spread-rate-accelerates.
- Cheung E. China coronavirus: hong kong researchers have already developed vaccine but need time to test it, expert reveals. South china morning post. https://www.scmp.com/news/hong-kong/healthenvironment/article/3047956/china-coronavirus-hong-kong-researchers-have.
- China Daily. Novel coronavirus vaccine being developed: China daily. https://www.chinadaily.com.cn/a/202001/26/WS5e2d1768a310128217273481.html.
- Xinhua. China fast-tracks novel coronavirus vaccine development xinhua. [Accessed 2020 Mar 28]. http://www.xinhuanet.com/english/2020-01/28/c_138739378.htm.
- Berkeley L Jr.. Us health officials fast-track coronavirus vaccine, hope to start clinical trial in three months. Cnbcmarkets. https://www.cnbc.com/2020/01/28/us-fast-tracks-coronavirus-vaccinehopes-to-start-trial-in-three-months.html.
- Bursztynsky J. J&j scientific officer ‘pretty confident’ they can create coronavirus vaccine as outbreak widens. Cnbcmarkets. https://www.cnbc.com/2020/01/27/jj-pretty-confident-it-can-create-chinacoronavirus-vaccine.html.
- Saskatchewan lab joins global effort to develop coronavirus vaccine. Canada: Kelly Geraldine Malone; 2020. [Accessed 2020 Mar 29]. https://www.cbc.ca/news/canada/saskatchewan/vido-intervac-working-on-coronavirus-vaccine-1.5439118
- In GeoVax. Geovax and bravovax (wuhan, china) to collaborate on development of coronavirus vaccine. [Accessed 2020 Mar 27]. https://www.geovax.com/news/geovax-and-bravovax-wuhan-china-to-collaborate-ondevelopment-of-coronavirus-vaccine.
- Clover Biopharmaceuticals. Clover initiates development of recombinant subunit- trimer vaccine for wuhan coronavirus (2019-ncov). [Accessed 2020 Apr 2]. http://www.cloverbiopharma.com/index.php?m=content&c=index&a=show&catid=11&id=40.
- Precision Vaccinations. Mrna vaccines can induce immune responses for 2019- ncov. [Accessed 2020 Mar 28]. https://www.precisionvaccinations.com/curevac-mrna-platform-specifically-suitable-rapidlyprovide-answer-viral-outbreak-situation-novel.
- Usdin S, J&j developing coronavirus vaccine, at least nine other vaccines under development. [Accessed 2020 Mar 30]. https://www.biocentury.com/bc-extra/company-news/2020-01-27/jj-developing-coronavirus-vaccineleast-nine-other-vaccines-under-.
- Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac. J. Allergy Immunol. 2020;38(1):10–18. doi:https://doi.org/10.12932/AP-200220-0773.
- Amin JA, Ghasemi S. The possible of immunotherapy for COVID-19: A systematic review. Int. Immunopharmacol. 2020;2:106455.
- Liu T, Zhang J, Yang Y, Zhang L, Ma H, Li Z, Zhang J, Cheng J, Zhang X, Wu G, et al. The potential role of IL-6 in monitoring coronavirus disease 2019. 2020. doi:https://doi.org/10.1101/2020.03.01.20029769
- Dalziel BD, Kissler S, Gog JR, Viboud C, Bjørnstad ON, Metcalf CJE, Grenfell BT. Urbanization and humidity shape the intensity of influenza epidemics in US cities. Sci. 2018;362(6410):75–79. doi:https://doi.org/10.1126/science.aat6030.
- Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KS, Lau EH, Wong JY. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New Eng. J. Of Med. 2020;382(13):1199–207. doi:https://doi.org/10.1056/NEJMoa2001316.
- Wang J, Tang K, Feng K, Lv W, High temperature and high humidity reduce the transmission of COVID-19. Available at SSRN 3551767 (2020).
- Financial Times, China’s Xi Jinping knew of coronavirus earlier than first thought, 2020. [ Accessed 2020 Mar 16]. https://www.ft.com/content/3da73290-5067-11ea-8841-482eed0038b1.
- Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeen RF, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013;13(9):752–61. doi:https://doi.org/10.1016/S1473-3099(13)70204-4.